Positive sentinel lymph node biopsy predicts the number of metastatic axillary nodes of breast cancer

被引:4
作者
Takei, Hiroyuki [1 ]
Kurosumi, Masafumi [2 ]
Yoshida, Takashi [1 ]
Ninomiya, Jun [1 ]
Ishikawa, Yuko [1 ]
Hayashi, Yuji [1 ]
Tozuka, Katsunori [1 ]
Asakawa, Hideki [1 ]
Oba, Hanako [2 ]
Inoue, Kenichi [3 ]
Tabei, Toshio [3 ]
机构
[1] Saitama Canc Ctr, Div Breast Surg, Ina, Saitama 3620806, Japan
[2] Saitama Canc Ctr, Dept Pathol, Ina, Saitama 3620806, Japan
[3] Saitama Canc Ctr, Div Breast Oncol, Ina, Saitama 3620806, Japan
关键词
Breast cancer; Sentinel lymph node biopsy; Number of metastatic axillary nodes; CARCINOMA; DISSECTION; RESECTION; TRIAL;
D O I
10.1016/j.breast.2009.05.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
It remains to be clarified whether a positive sentinel lymph node biopsy (SLNB) can predict the number of metastatic axillary nodes. This study examined a consecutive series of women with unilateral invasive breast cancer who underwent axillary lymph node dissection after an intra-operative positive SLNB. The numbers of positive and negative sentinel lymph nodes (SLNs) were analyzed for a likelihood of pN1a, pN2a, and pN3a diseases as per the UICC TNM classification. Of the 368 study patients, 165 (45%) had one positive SLN and one or more negative SLNs. This result represented the most common combination of positive and negative SLNs. It was also the most predictive indicator (93%) of pN1a disease and the least predictive indicator (7% or 0%) of pN2a or pN3a disease, respectively. The numbers of positive and negative SLNs can predict the number of metastatic axillary nodes in breast cancer patients. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:244 / 247
页数:4
相关论文
共 26 条
[1]  
Abe O, 2005, LANCET, V366, P2087, DOI 10.1016/s0140-6736(05)66544-0
[2]   Solitary positive sentinel lymph node accompanied by negative sentinel lymph node(s) is predictive of a negative completion axillary lymph node dissection [J].
Alkhatib, Weesam ;
Connor, Carol ;
Fang, Fan .
AMERICAN JOURNAL OF SURGERY, 2007, 194 (06) :856-859
[3]   Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer [J].
Fisher, B ;
Anderson, S ;
Bryant, J ;
Margolese, RG ;
Deutsch, M ;
Fisher, ER ;
Jeong, J ;
Wolmark, N .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (16) :1233-1241
[4]   LYMPHATIC MAPPING AND SENTINEL LYMPHADENECTOMY FOR BREAST-CANCER [J].
GIULIANO, AE ;
KIRGAN, DM ;
GUENTHER, JM ;
MORTON, DL .
ANNALS OF SURGERY, 1994, 220 (03) :391-401
[5]   Progress and promise:: highlights of the international expert consensus on the primary therapy of early breast cancer 2007 [J].
Goldhirsch, A. ;
Wood, W. C. ;
Gelber, R. D. ;
Coates, A. S. ;
Thuerlimann, B. ;
Senn, H.-J. ;
Members, Panel .
ANNALS OF ONCOLOGY, 2007, 18 (07) :1133-1144
[6]   Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer [J].
Hwang, RF ;
Krishnamurthy, S ;
Hunt, KK ;
Mirza, N ;
Ames, FC ;
Feig, B ;
Kuerer, HM ;
Singletary, SE ;
Babiera, G ;
Meric, F ;
Akins, JS ;
Neely, J ;
Ross, MI .
ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (03) :248-254
[7]   Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma - A metaanalysis [J].
Kim, T ;
Giuliano, AE ;
Lyman, GH .
CANCER, 2006, 106 (01) :4-16
[8]   Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial [J].
Krag, David N. ;
Anderson, Stewart J. ;
Bjulian, Thomas ;
Brown, Ann M. ;
Harlow, Seth P. ;
Ashikaga, Takamaru ;
Weaver, Donald L. ;
Miller, Barbara J. ;
Jalovec, Lynne M. ;
Frazier, Thomas G. ;
Noyes, R. Dirk ;
Robidoux, Andre ;
Scarth, Hugh M. C. ;
Mammolito, Denise M. ;
McCready, David R. ;
Mamounas, Eleftherios P. ;
Costantino, Joseph P. ;
Wolmark, Norman .
LANCET ONCOLOGY, 2007, 8 (10) :881-888
[9]   SURGICAL RESECTION AND RADIOLOCALIZATION OF THE SENTINEL LYMPH-NODE IN BREAST-CANCER USING A GAMMA-PROBE [J].
KRAG, DN ;
WEAVER, DL ;
ALEX, JC ;
FAIRBANK, JT .
SURGICAL ONCOLOGY-OXFORD, 1993, 2 (06) :335-340
[10]  
Kurosumi M, 2001, ONCOL REP, V8, P1051